Atlas Trials

Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of CDX 6114 in PKU Patients

Clinical trial NCT04256655 · WITHDRAWN

Trial details

NCT number
NCT04256655
Sponsor
Société des Produits Nestlé (SPN)
Status
WITHDRAWN
Phase
Phase 1
Study type
INTERVENTIONAL
Phenylketonurias
Start date
2020-12-01
Primary completion
2021-12-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.